Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis

Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications

(2020) Daniel J Drucker   ENDOCRINE REVIEWS

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

(2020) Zheyong Huang et al.   Annals of Translational Medicine

Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis

(2020) Xiang Wang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study

(2020) Mohamad Nikpouraghdam et al.   JOURNAL OF CLINICAL VIROLOGY

Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020

(2020) Yi Zheng et al.   PHARMACOLOGICAL RESEARCH

The effect of obesity on lung function

(2018) Anne E. Dixon et al.   Expert Review of Respiratory Medicine

Meta-analysis in clinical trials revisited

(2015) Rebecca DerSimonian et al.   Contemporary Clinical Trials